e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Cell signalling and inflammation: what's new in 2013?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Combination therapy may be beneficial for the treatment of lymphangioleiomyomatosis
L. Moir, H. Y. Ng, B. Oliver, J. Burgess, V. Krymskaya, J. Black (Sydney, Australia; Philadelphia, United States Of America)
Source:
Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Session:
Cell signalling and inflammation: what's new in 2013?
Session type:
Poster Discussion
Number:
4734
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Moir, H. Y. Ng, B. Oliver, J. Burgess, V. Krymskaya, J. Black (Sydney, Australia; Philadelphia, United States Of America). Combination therapy may be beneficial for the treatment of lymphangioleiomyomatosis. Eur Respir J 2013; 42: Suppl. 57, 4734
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Combination therapy in the era of immunotherapy
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019
Cell therapy in ILD
Source: ERS Course 2016
Year: 2016
Cell therapy for lung disease
Source: Eur Respir Rev, 26 (144) 170044; 10.1183/16000617.0044-2017
Year: 2017
Cell therapy for lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
Cell therapy: a novel approach for the treatment of lung cancer and fibrosis
Source: Annual Congress 2010 - Too close for comfort: common pathogenic mechanisms in lung cancer and fibrosis
Year: 2010
Long-term sirolimus treatment in lymphangioleiomyomatosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005
Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Stem cell therapy in IPF
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014
Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM)
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Outcome of two patients with lymphangioleiomyomatosis without anti-estrogen therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 96s
Year: 2006
Tuberculosis screening in patients receiving biological therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
First-line therapy
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer
Source: Eur Respir Rev 2014; 23: 30-35
Year: 2014
Concomitant radiotherapy and targeted therapies
Source: International Congress 2019 – New perspectives in thoracic surgical oncology
Year: 2019
Effects of two immunosuppressive triple therapies on inflammatory cells in lung
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Effectiveness of oral metronomic Vinorelbine versus Docetaxel as second-line treatment in Non-Small Cell Lung Cancer patients in real life
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept